However, using our novel Treg-specific pSTAT5 assay, the response to stimulation was found in the FOXP3+ subset of CD4+ T-cells also from patients with advanced CLL, whose AIM response was absent. The gene discussed is FOXP3; the disease is B-cell chronic lymphocytic leukemia.